Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder

Overview

Journal Ann Fam Med

Specialty Public Health

Date 2017 Jul 12

PMID 28694273

Citations 91

Authors

C Holly A Andrilla

Cynthia Coulthard

Eric H Larson

Affiliations

Soon will be listed here.

Abstract

Opioid use disorder is a serious public health problem. Management with buprenorphine is an effective, office-based, medication-assisted treatment, but 60.1% of rural counties in the United States lack a physician with a Drug Enforcement Agency waiver to prescribe buprenorphine. This national study surveyed all rural physicians who have received a waiver in the United States and found that those who were not actively prescribing buprenorphine reported significantly more barriers than those who were, regardless of whether they were treating the maximum number of patients their waiver allowed. These findings suggest the need for tailored strategies to address barriers to providing buprenorphine for opioid use disorder and to support physicians who are adding or maintaining this service.

Citing Articles

Staff-reported barriers and facilitators to the implementation of healthcare interventions within regional and rural areas: a rapid review.

Chapman A, Buccheri A, Mohotti D, Shee A, Huggins C, Alston L BMC Health Serv Res. 2025; 25(1):331.

PMID: 40033247 PMC: 11877690. DOI: 10.1186/s12913-025-12480-8.

Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices.

Hall T, Mendez D, Sobczak C, Mathieu S, Wiggins K, Cebuhar K Ann Fam Med. 2025; 23(1):44-51.

PMID: 39805692 PMC: 11772038. DOI: 10.1370/afm.3190.

The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.

Fenstemaker C, Abrams E, King K, Obringer B, Brook D, Go V J Gen Intern Med. 2024; .

PMID: 39668316 DOI: 10.1007/s11606-024-09260-1.

Behavioral health treatment delivery by social workers in accountable care organizations.

Miller-Rosales C, Meara E, Murphey J, Dasgupta A, Lewinson T Soc Work Health Care. 2024; 63(8-10):600-622.

PMID: 39576745 PMC: 11666320. DOI: 10.1080/00981389.2024.2427750.

Increasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.

Holtrop J, Mullen R, Curcija K, Rubinson C, Westfall J, Nease Jr D Front Med (Lausanne). 2024; 11:1450672.

PMID: 39416870 PMC: 11479968. DOI: 10.3389/fmed.2024.1450672.

References

Quest T, Merrill J, Roll J, Saxon A, Rosenblatt R . Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. J Opioid Manag. 2012; 8(1):29-38. PMC: 4367201. DOI: 10.5055/jom.2012.0093. View

Li X, Shorter D, Kosten T . Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opin Pharmacother. 2014; 15(15):2263-75. DOI: 10.1517/14656566.2014.955469. View

Thomas C, Fullerton C, Kim M, Montejano L, Lyman D, Dougherty R . Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2013; 65(2):158-70. DOI: 10.1176/appi.ps.201300256. View

Stein B, Pacula R, Gordon A, Burns R, Leslie D, Sorbero M . Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. Milbank Q. 2015; 93(3):561-83. PMC: 4567853. DOI: 10.1111/1468-0009.12137. View

DeFlavio J, Rolin S, Nordstrom B, Kazal Jr L . Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015; 15:3019. View